TITLE

Vaccine made from HIV fragments bolsters immune response

AUTHOR(S)
Joyce, Christopher
PUB. DATE
June 1991
SOURCE
New Scientist;6/22/91, Vol. 130 Issue 1774, p24
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reveals that experiments have indicated that the immune systems of people infected with HIV may be bolstered by vaccinations with a fragment of the virus. Possible effect of HIV's protein coat on the immune system; Vaccine developed by MicroGeneSys; Safety trials of the vaccine in uninfected volunteers; The trial in HIV positive people conducted at Walter Reed Army Institute of Research in Washington, D.C.; More.
ACCESSION #
9107221996

 

Related Articles

  • Viral and Immunologic Examination of Human Immunodeficiency Virus Type 1-Infected, Persistently Seronegative Persons. Ellenberger, Dennis L.; Dorn, Jonathan; Folks, Thomas M.; Sullivan, Patrick S.; Schable, Charles; Spira, Thomas J.; Lal, Renu B. // Journal of Infectious Diseases;10/1/99, Vol. 180 Issue 4, p1033 

    Examines the viral and immunologic complications of HIV-positive patients. Determination of whether persistent seronegativity was attributable to immune dysfunction or infection; Results of the in vitro stimulation of peripheral blood mononuclear cells.

  • Me, and Walter Reed. Hodge, Jennifer M. // Military Medicine;Jun2004, Vol. 169 Issue 6, following p497 

    Pays tribute to Walter Reed, the discoverer of a cure for yellow fever.

  • Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture. Rodríguez, José W.; Pagan, Nat O.; Ocasio, María C.; Ríos, Zilka; Cubano, Luis A.; Boukli, Nawal M.; Otero, Miguel; Hunter, Robert; Nair, Madhavan P.; Rios-Olivares, Eddy // American Journal of Infectious Diseases;2007, Vol. 3 Issue 4, p266 

    Partial immune restoration may be obtained with highly active antiretroviral therapy (HAART), but specific anti-HIV-1 immune responses do not appear to improve substantially. We have demonstrated that a soluble factor(s) induced by a mixture of inactivated influenza and bacterial vaccines called...

  • HCV Does Not Accelerate HIV Progression or Impede Treatment.  // Guide;Aug2006, Vol. 26 Issue 8, p65 

    The article discusses the study regarding impede treatment of HIV on Hepatitis C Virus. HIV is known to increase the severity of hepatitis C infection. According to the results of a massive study by researchers from the U.S. Centers for Disease Control and Prevention that hepatitis C virus does...

  • Chapter 1: Overcoming AIDS: the 'Next Agenda'.  // Report on the Global HIV/AIDS Epidemic: UNAIDS - 2004;1/1/2004, p11 

    Chapter 1 of the book "2004 Report on the global AIDS epidemic" is presented. It explores the agenda in the determination of the resources needed in the prevention of AIDS, care and to alleviate the impact. It highlights the factors that drive the epidemic, as well as the vulnerability and...

  • Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099. Journot, Valérie; Chêne, Geneviève; De Castro, Nathalie; Rancinan, Corinne; Cassuto, Jill-Patrice; Allard, Christian; Vildé, Jean-Louis; Sobel, Alain; Garré, Michel; Molina, Jean-Michel // Clinical Infectious Diseases;6/15/2006, Vol. 42 Issue 12, p1790 

    Background. Efavirenz (EFV) is a highly active antiretroviral drug, use of which is associated with frequent (although transient) neurosensorial adverse reactions. Whether the use of EFV is associated with the risk of depression or suicide remains controversial. Methods. ALIZE-ANRS (Agence...

  • HIV Type 1 RNA Level as a Clinical Indicator of Renal Pathology in HIV-Infected Patients. Estrella, Michelle; Fine, Derek M.; Gallant, Joel E.; Rahman, M. Hafizur; Nagajothi, Nagapradeep; Racusen, Lorraine C.; Scheel, Paul J.; Atta, Mohamed G. // Clinical Infectious Diseases;8/1/2006, Vol. 43 Issue 3, p377 

    To determine the value of human immunodeficiency virus type 1 (HIV-1) RNA level in distinguishing HIV-associated nephropathy from non-HIV-associated nephropathy renal pathological conditions, we retrospectively compared renal histopathological findings for 86 HIV-infected patients according to...

  • Declining Gastrointestinal Opportunistic Infections in HIV-Infected Persons: A Triumph of Science and a Challenge for Our HAARTs and Minds. Raufman, Jean-Pierre // American Journal of Gastroenterology;Jul2005, Vol. 100 Issue 7, p1455 

    Gastrointestinal opportunistic infections, primarily oral and esophageal candidiasis, are common in persons infected with the human immunodeficiency virus (HIV) and contribute significantly to morbidity and mortality. Research early in the AIDS epidemic established a strong association between...

  • Reframing "Prevention with Positives": Incorporating Counseling Techniques That Improve the Health of HIV-Positive Patients. Gerbert, Barbara; Danley, Dale W.; Herzig, Karen; Clanon, Kathleen; Ciccarone, Daniel; Gilbert, Paul; Allerton, Michael // AIDS Patient Care & STDs;Jan2006, Vol. 20 Issue 1, p19 

    Federal HIV prevention strategy seeks to increase efforts by health care providers to identify and reduce their HIV-positive patients' transmission-related behaviors. Implementation of these recommendations will be hindered if providers perceive these efforts have the potential to harm their...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics